[TVTX] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
23-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 5.50%
YoY- -27.63%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 37,095 59,697 56,993 55,868 53,496 54,167 48,487 -16.33%
PBT -89,229 -85,565 -86,253 -65,760 -69,511 -66,979 -75,919 11.35%
Tax -12 65 78 63 145 53 52 -
NP 150,735 -85,630 -86,331 -65,823 -69,656 -67,032 -75,971 -
Tax Rate - - - - - - - -
Total Cost -113,640 145,327 143,324 121,691 123,152 121,199 124,458 -
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 406.35 -143.44 -151.48 -117.82 -130.21 -123.75 -156.68 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.99 -1.13 -1.27 -1.03 -1.09 -1.05 -1.20 -12.02%
EPS Diluted -0.99 -1.13 -1.27 -1.03 -1.09 -1.05 -1.20 -12.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.